Certainly an ever expanding pipeline further cementing PIQ as a...

Certainly an ever expanding pipeline further cementing PIQ as a long term buy and hold for me.

We know COPD also had successful POC biomarkers & with Endo due soon it's reassuring to see that Proteomics International as a company and a team of scientist are able to convert R&D into meaningful utility. The issue as we know is commercialisation but that is usually more a 'time' factor as opposed to R&D's "if" factor.

So very pleasing to see even further evidence of the underlying proteomic sequencing techniques that Richard and his team are using continue to bear fruit.